Search

Baloxavir Patent for Influenza Prevention Transmission

The EPO published application EP3714889A1 on April 15, 2026, disclosing the Baloxavir patent covering use of the antiviral compound for prevention of influenza virus transmission. The application is co-owned by F. Hoffmann-La Roche AG and Shionogi & Co., Ltd, with designated states covering all major European markets (DE, FR, GB, IT, ES, NL, BE, AT, CH, and 21 others).